Digene Files Patent Suit Against Third Wave
Digene makes the only U.S. Food and Drug Administration-approved test that detects human papillomavirus 52.
According to Digene's complaint, filed Thursday, Third Wave’s Invader HPV A9 Oligo Mix infringes Digene’s patent on its test. The complaint said the infringement has occurred since at least Oct. 11, 2005.
A Third Wave spokesman did not return phone messages for comment.
Digene is seeking an...
To view the full article, register now.